According to Abeona Therapeutics 's latest financial reports the company's current earnings (TTM) are -$54.19 M. In 2022 the company made an earning of -$33.71 M an increase over its 2021 earnings that were of -$84.94 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$54.19 M | 60.79% |
2022 | -$33.71 M | -60.32% |
2021 | -$84.94 M | 0.83% |
2020 | -$84.24 M | 10.42% |
2019 | -$76.29 M | 28.68% |
2018 | -$59.29 M | 117% |
2017 | -$27.32 M | 24.9% |
2016 | -$21.88 M | 50.58% |
2015 | -$14.53 M | -45.75% |
2014 | -$26.78 M | -701.89% |
2013 | $4.44 M | -111.96% |
2012 | -$37.19 M | 2296.01% |
2011 | -$1.56 M | -79.99% |
2010 | -$7.76 M | -19.83% |
2009 | -$9.68 M | -45.84% |
2008 | -$17.87 M | 158.91% |
2007 | -$6.9 M | 33.33% |
2006 | -$5.18 M | -31.61% |
2005 | -$7.57 M | -16.65% |
2004 | -$9.08 M | 10.54% |
2003 | -$8.22 M | -8.67% |
2002 | -$9 M | 49.21% |
2001 | -$6.03 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Merck MRK | $3.03 B | -5,700.87% | ๐บ๐ธ USA |
Taro Pharmaceutical TARO | $43.72 M | -180.69% | ๐ฎ๐ฑ Israel |